5
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Correspondence

, , , , , , , , & show all
Pages 139-144 | Published online: 07 Jul 2009

References

  • Diamantstein T, Osawa H. The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies. Immunol Rev 1986; 92: 875–84
  • Kupiec-Weglinski J W, Hahn H J, Kirkman R L, Volk H D, Mouzaki A, Di Stefano R, Tellides G, Dallman M, Morris P J, Strom T B, Tilney N L, Diamantstein T. Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy. Transplant Proc 1988; 20(Suppl. 2)207–16
  • Hahn H J, Lucke S, Kloting I, Volk H D, von Baehr R, Diamantstein T. Curing BB rats of freshly manifested diabetes by short-term treatment with a combination of a monoclonal anti-interleukin 2 receptor antibody and a subtherapeutic dose of Cyclosporin A. Eur J Immunol 1987; 17: 1075–78
  • Lucke S, Besch W, Kauert C, Hahn H J. The endocrine pancreas of BB/OK-rats before and at diagnosis of hyperglycaemia. Exp Clin Endocrinol 1988; 91: 161–70
  • Prowse S J, Bellgrau D, Lafferty K J. Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes 1986; 35: 110
  • Selawry H, Fojaco R, Whittington K. Extended survival of MHC-compatible islet grafts from diabetes-resistant donors in spontaneously diabetic BB/W-rat. Diabetes 1987; 36: 1061–67
  • Kupiec-Weglinski J W, Diamantstein T, Tilney N L, Strom T B. Therapy with monoclonal antibody to interleukin-2 receptor spares suppressor T-cells and prevents or reverses acute allograft rejection in rats. Proc Natl Acad Sci USA 1986; 83: 2624–27
  • Banga J P, Barnett P S, Mahadevan D, McGregor A M. Immune recognition of antigen and its relevance to autoimmune disease: recent advances at the molecular level. Eur J Clin Invest 1989; 19: 107–116
  • Banga J P, Pryce G, Hammond L, Roitt I M. Structural features of the autoantigens involved in thyroid autoimmune disease: the thyroid microsomal/microvillar antigen. Mol Immunol 1985; 22: 629–642
  • Kimura S, Kotani T, McBride O M, Umeki K, Hirai K, Nakayama T, Ohtaki S. Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping and identification of two alternately spliced mRNAs. Proc Nall Acad Sci 1987; 84: 5555–5559
  • Doble N, Banga J P, Pope R, Lalor E, Kilduff P, McGregor A M. Autoantibodies to the thyroid microsomal/thyroid peroxidase antigen are polyclonal and directed to several distinct antigenic sites. Immunol 1988; 64: 23–29
  • Banga J P, Tomlinson R WS, Doble N, Odell E, McGregor A M. Thyroid microsomal/thyroid peroxidase autoantibodies show discrete patterns of cross-reactivity to myeloperoxidase, lactoperoxidase and horseradish peroxidase. Immunol 1989; 67: 197–204
  • Banga J P, Barnett P S, Ewins D L, Page M J, McGregor A M. Analysis of autoantigenic determinants of thyroid peroxidase antigen, generated using polymerase chain reaction. Mol Biol of Autoimmune Disease, A G Demaine, J P Banga, A M. McGregor. Springer-Verlag, Berlin 1989, in press
  • Barnett P S, Banga J P, Watkins J, Page M J, McGregor A M. Nucleotide sequence of the alternatively spliced human thyroid peroxidase cDNA, TPO-2. Nuc. Acid Res 1989, in press
  • Smith D B, Johnson K S. Single step purification of polypeptides expressed in Eschericia coli as fusions with glutathione S-transferase. Gene 1988; 67: 31–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.